PharmaCyte Biotech Inc (PMCB) — Tangible Net Worth Ratio
PharmaCyte Biotech Inc (PMCB) has a Tangible Net Worth Ratio of 96.1% as of January 2026. This metric is calculated by deducting intangible assets ($1.55 Million) from net assets ($39.40 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See PharmaCyte Biotech Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
PharmaCyte Biotech Inc Tangible Net Worth Ratio (2006–2025)
This chart shows how PharmaCyte Biotech Inc's Tangible Net Worth Ratio has changed across 16 annual periods from 2006 to 2025. As of January 2026, the ratio stands at 96.1%, reflecting net assets of $39.40 Million with intangible assets of $1.55 Million USD. See PharmaCyte Biotech Inc (PMCB) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for PharmaCyte Biotech Inc (2006–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for PharmaCyte Biotech Inc from 2006 to 2025, covering 16 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see PharmaCyte Biotech Inc (PMCB) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 97.0% | $51.89 Million | $1.55 Million | $55.17 Million | ▲ +0.9 pp |
| 2024 | 96.1% | $39.51 Million | $1.55 Million | $59.90 Million | ▲ +1.0 pp |
| 2023 | 95.1% | $72.69 Million | $3.55 Million | $73.28 Million | ▼ -0.9 pp |
| 2022 | 96.1% | $89.92 Million | $3.55 Million | $90.62 Million | ▲ +49.2 pp |
| 2021 | 46.9% | $6.68 Million | $3.55 Million | $7.40 Million | ▲ +16.6 pp |
| 2020 | 30.3% | $5.09 Million | $3.55 Million | $6.17 Million | ▲ +0.7 pp |
| 2019 | 29.6% | $5.04 Million | $3.55 Million | $5.78 Million | ▼ -8.9 pp |
| 2018 | 38.5% | $5.77 Million | $3.55 Million | $6.41 Million | ▼ -17.6 pp |
| 2017 | 56.1% | $8.09 Million | $3.55 Million | $8.67 Million | ▲ +10.5 pp |
| 2016 | 45.6% | $6.52 Million | $3.55 Million | $7.16 Million | ▲ +5.4 pp |
| 2015 | 40.2% | $5.94 Million | $3.55 Million | $7.95 Million | ▼ -20.1 pp |
| 2014 | 60.3% | $8.94 Million | $3.55 Million | $9.32 Million | ▼ -18.2 pp |
| 2009 | 78.5% | $3.99 Million | $857.02K | $6.84 Million | ▼ -9.9 pp |
| 2008 | 88.4% | $7.44 Million | $863.40K | $7.62 Million | ▲ +8.5 pp |
| 2007 | 79.8% | $4.29 Million | $863.87K | $4.41 Million | ▼ -20.2 pp |
| 2006 | 100.0% | $4.41 Million | $0.00 | $5.14 Million | — |